Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Respir Med

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    November 2021
  1. LO CASCIO CM, Kaul V, Dhooria S, Agrawal A, et al
    Diagnosis of tuberculous pleural effusions: A review.
    Respir Med. 2021;188:106607.
    PubMed     Abstract available

    August 2021
  2. VIANA MACHADO F, Morais C, Santos S, Reis R, et al
    Evaluation of CD8(+) response in QuantiFERON-TB Gold Plus as a marker of recent infection.
    Respir Med. 2021;185:106508.
    PubMed     Abstract available

    May 2021
  3. MORGAN C, Barrett J, Brown A, Coughlan C, et al
    Respiratory samples to diagnose tuberculosis in the absence of chest x-ray abnormalities.
    Respir Med. 2021;185:106488.
    PubMed     Abstract available

    February 2021
  4. HAN DW, Jo KW, Kim OH, Shim TS, et al
    Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Respir Med. 2021;179:106340.
    PubMed     Abstract available

    December 2020
  5. TORRE A, Aliberti S, Castellotti PF, Cirillo DM, et al
    Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.
    Respir Med. 2020;175:106204.
    PubMed     Abstract available

    September 2020
  6. WILSON M, O'Connor B, Matigian N, Eather G, et al
    Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series.
    Respir Med. 2020;173:106163.
    PubMed     Abstract available

    June 2020
  7. KANG H, Jo KW, Jeon D, Yim JJ, et al
    Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea.
    Respir Med. 2020;167:105956.
    PubMed     Abstract available

    February 2020
  8. SONG WM, Li YF, Liu JY, Tao NN, et al
    Drug resistance of previously treated tuberculosis patients with diabetes mellitus in Shandong, China.
    Respir Med. 2020;163:105897.
    PubMed     Abstract available

  9. PEREIRA GR, Barbosa MS, Dias NJD, Dos Santos FF, et al
    Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    Respir Med. 2020;162:105876.
    PubMed     Abstract available

    January 2020
  10. IM Y, Lee J, Kim SJ, Koh WJ, et al
    Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors.
    Respir Med. 2020;161:105853.
    PubMed     Abstract available

  11. PIUBELLO A, Souleymane MB, Hassane-Harouna S, Yacouba A, et al
    Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
    Respir Med. 2020;161:105844.
    PubMed     Abstract available

    October 2019
  12. HUANG CT, Lee MR, Ruan SY, Tsai YJ, et al
    Prognostic value of the mitogen response in the interferon-gamma release assay in patients with culture-confirmed tuberculosis.
    Respir Med. 2019;158:49-54.
    PubMed     Abstract available

    April 2019
  13. LEE E, Shim JY, Kim HY, Suh DI, et al
    Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study.
    Respir Med. 2019;150:8-14.
    PubMed     Abstract available

    January 2019
  14. YOO IY, Huh HJ, Kang OK, Jhun BW, et al
    Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Respir Med. 2019;146:71-75.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.